These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Levodopa in the treatment of Parkinson's disease: current controversies. Olanow CW; Agid Y; Mizuno Y; Albanese A; Bonuccelli U; Damier P; De Yebenes J; Gershanik O; Guttman M; Grandas F; Hallett M; Hornykiewicz O; Jenner P; Katzenschlager R; Langston WJ; LeWitt P; Melamed E; Mena MA; Michel PP; Mytilineou C; Obeso JA; Poewe W; Quinn N; Raisman-Vozari R; Rajput AH; Rascol O; Sampaio C; Stocchi F Mov Disord; 2004 Sep; 19(9):997-1005. PubMed ID: 15372588 [TBL] [Abstract][Full Text] [Related]
26. [Dopamine agonist therapy in early Parkinson's disease. A survey of a Cochrane review]. Bode M Ugeskr Laeger; 2009 Oct; 171(41):2996-9. PubMed ID: 19814927 [TBL] [Abstract][Full Text] [Related]
28. [Idiopathic Parkinson's disease: practical hints for the treatment]. Ludin HP Praxis (Bern 1994); 2005 Jul; 94(30-31):1147-50. PubMed ID: 16117469 [TBL] [Abstract][Full Text] [Related]
29. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]. Klivényi P; Vécsei L Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097 [TBL] [Abstract][Full Text] [Related]
30. Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease. Olanow CW; Obeso JA; Stocchi F Nat Clin Pract Neurol; 2006 Jul; 2(7):382-92. PubMed ID: 16932589 [TBL] [Abstract][Full Text] [Related]